Adiuvo Investments SA
WSE:ADV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (8), the stock would be worth zł-0.05 (109% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -93.2 | zł0.57 |
0%
|
| Industry Average | 8 | zł-0.05 |
-109%
|
| Country Average | 11.3 | zł-0.07 |
-112%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
A
|
Adiuvo Investments SA
WSE:ADV
|
7.5m PLN | -93.2 | -1.5 | |
| US |
|
BlackRock Inc
NYSE:BLK
|
161.7B USD | 19.4 | 25.9 | |
| US |
|
Blackstone Inc
NYSE:BX
|
152.6B USD | 22.4 | 52 | |
| CA |
|
Brookfield Corp
NYSE:BN
|
104.2B USD | 17 | 91.4 | |
| US |
|
Bank of New York Mellon Corp
NYSE:BK
|
94.9B USD | 0 | 17.9 | |
| US |
|
KKR & Co Inc
NYSE:KKR
|
93.1B USD | 287.5 | 41.6 | |
| ZA |
N
|
Ninety One Ltd
JSE:NY1
|
83.8B ZAR | -41.1 | 24.6 | |
| CA |
|
Brookfield Asset Management Inc
NYSE:BAM
|
79B USD | 29.1 | 31.8 | |
| CA |
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
109.6B CAD | 28.7 | 31.4 | |
| US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
68.6B EUR | 29.1 | 31.8 | |
| US |
|
Ameriprise Financial Inc
NYSE:AMP
|
42.1B USD | 12.2 | 11.8 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 8.1 |
| Median | 11.3 |
| 70th Percentile | 16 |
| Max | 313.7 |
Other Multiples
Adiuvo Investments SA
Glance View
Adiuvo Investment SA provides financial services. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 14 full-time employees. The company went IPO on 2015-05-27. The firm focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The firm is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
